recurrent neuroblastoma
Showing 1 - 25 of 44
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +118 more
Jan 27, 2023
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,
Recruiting
- High Risk Neuroblastoma
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +10 more
Jan 19, 2023
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide
Active, not recruiting
- Localized Resectable Neuroblastoma
- +5 more
- Aldesleukin
- +6 more
-
Birmingham, Alabama
- +196 more
Dec 30, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Recurrent Neuroblastoma Trial in Germany (metronomic therapy)
Recruiting
- Recurrent Neuroblastoma
- metronomic therapy
-
Bonn, Germany
- +7 more
Nov 3, 2022
Patients With Previously Diagnosed High-Risk Neuroblastoma
Active, not recruiting
- Recurrent Neuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Birmingham, Alabama
- +97 more
Oct 28, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
- Pharmacokinetic Study
- Ulixertinib
-
Birmingham, Alabama
- +108 more
Oct 19, 2022
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,
Withdrawn
- Constitutional Mismatch Repair Deficiency Syndrome
- +11 more
- Biospecimen Collection
- +2 more
-
Palo Alto, California
- +8 more
Sep 9, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +37 more
-
Birmingham, Alabama
- +171 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto
Recruiting
- Malignant Solid Neoplasm
- +26 more
- Ensartinib
- +2 more
-
Birmingham, Alabama
- +121 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +30 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +123 more
Aug 23, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small
Recruiting
- Desmoplastic Small Round Cell Tumor
- +11 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jun 26, 2022
Recurrent Neuroblastoma, Neuroblastoma Trial in Oklahoma City, Dallas, Fort Worth (Fenretinide Lym-X-Sorb Oral Powder,
No longer available
- Recurrent Neuroblastoma
- Neuroblastoma
- Fenretinide Lym-X-Sorb Oral Powder
- Ketoconazole
-
Oklahoma City, Oklahoma
- +2 more
Mar 17, 2022
Pleuropulmonary Blastoma, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Neuroblastoma Trial in United States
Completed
- Pleuropulmonary Blastoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +68 more
Jan 4, 2022
Recurrent Neuroblastoma Trial in Canada, United States (biological, drug, other)
Completed
- Recurrent Neuroblastoma
- hu14.18-IL2 fusion protein
- +3 more
-
Birmingham, Alabama
- +75 more
Oct 4, 2019
Disseminated Neuroblastoma, Recurrent Neuroblastoma Trial in Canada, United States (ABT-751, quality-of-life assessment)
Completed
- Disseminated Neuroblastoma
- Recurrent Neuroblastoma
- ABT-751
- quality-of-life assessment
-
Birmingham, Alabama
- +11 more
Jul 2, 2019